Comment by
Rumpl3StiltSkin on Dec 29, 2020 11:31pm
This discovery benefits her Directly via her commpany, and indirectly from TLT, who benefit semi-directly from this find.
Comment by
m8magic on Dec 30, 2020 12:30am
but the commercial avenue is secured by TLT correct..??
Comment by
CancerSlayer on Dec 30, 2020 1:02am
TLT has patent/commercial protection for Ruthenium-based TLD-1433 in its use against hyper-proliferating cells (such as cancer) & microbial pathogens (which includes bacteria, fungi, viruses & protozoa). All is good m8magic.